Chester County News and Community Website
The future of search-powered technology is looking very bright! With the growth of data, businesses are increasingly turning to search engines and other forms of search-powered technology to help them …
The Future of Search-Powered Technology: Harnessing the Power of Data Read More
EXTON, PA — Ricoh USA, Inc. recently announced RICOH 3D for Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its craniomaxillofacial (CMF) and orthopedic patient-specific anatomic modeling.
Ricoh’s Healthcare Solution Receives FDA 510(k) Clearance for Craniomaxillofacial and Orthopedic Anatomic Modeling Read More
WEST GROVE, PA — On May 12, the Avon Grove High School (AGHS) aerial drones team received the Modeling and 3D Printing award at the 2022 Robotics Education and Competition …
Avon Grove High School Aerial Drones Team Earns Award Read More
PITTSBURGH, PA — Governor Tom Wolf joined industry leaders and stakeholders Monday at the Pittsburgh Manufacturing Summit to highlight his legacy of support for manufacturing in Pennsylvania and how this …
Gov. Wolf Declares Pennsylvania Well-Positioned to Be Leader in National Clean Energy Transition Read More
HARRISBURG, PA — Governor Tom Wolf this week announced that Pennsylvania is working with energy, organized labor, and environmental stakeholders to support a path forward for industrial sector decarbonization with …
Gov. Wolf Announces Aggressive Push to Secure Clean Hydrogen Hub in Pennsylvania Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) states that the independent Data and Safety Monitoring Board (DSMB) for its Phase 1/2 clinical trial of OCU400, the Company’s flagship modifier gene …
Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the first patient has been recently dosed in the Phase 1/2 clinical trial of OCU400, a modifier gene therapy candidate for …
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration Read More
WASHINGTON, D.C. — The following quote is attributed to CDRH’s William Maisel, M.D.,M.P.H., director of the Office of Product Evaluation and Quality and Ed Margerrison, Ph.D., director of the Office …
FDA Seeks Public Input on 3D Printing of Medical Devices at the Point of Care Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the U.S. Food and Drug Administration (FDA) recently accepted the company’s Investigational New Drug application (IND) to initiate a first-in-human clinical …
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application Read More
KING OF PRUSSIA, PA — NeuExcell Therapeutics, Inc. announced the recent signing of a lease with The Discovery Labs in King of Prussia, PA. This lease sets the stage for …
NeuExcell Therapeutics Establishes Corporate Headquarters in Philadelphia Region Read More